Related Experiment Video

Updated: May 3, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

4.9K

Inflammation in coronary artery disease

Georgios Christodoulidis1, Timothy J Vittorio, Marat Fudim

  • 1From the *Department of Internal Medicine, Winthrop University Hospital, Mineola, NY; †St. Francis Hospital, The Heart Center, Division of Cardiology, Center of Advanced Cardiac Therapeutics, Roslyn, NY; ‡Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN; §Department of Medicine, Emory University School of Medicine, Atlanta, GA; and ¶Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY.

Cardiology in Review
|January 21, 2014
PubMed

Insights

Coronary artery disease (CAD) involves inflammation, not just lipids. Understanding these inflammatory processes and markers is key to improving patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Pathophysiology

Background:

  • Coronary artery disease (CAD) is a major cause of mortality.
  • CAD was previously thought to be solely caused by lipid accumulation.
  • Emerging evidence highlights the critical role of inflammation in CAD development.

Purpose of the Study:

  • To review current evidence on inflammation's role in CAD pathogenesis.
  • To discuss the impact of inflammatory markers on clinical outcomes.
  • To explore how modifying inflammation may affect CAD progression.

Main Methods:

  • Literature review of basic science research and clinical studies.
  • Analysis of immune mechanisms and metabolic risk factors in CAD.
  • Examination of inflammatory markers and their association with CAD outcomes.

Main Results:

  • Inflammation is integral to all stages of CAD.
  • Interactions between immune responses and metabolic factors drive lesion development.
  • Modifiable inflammatory markers show potential for impacting clinical outcomes.

Conclusions:

  • Inflammation is a central driver of coronary artery disease.
  • Targeting inflammatory pathways represents a promising therapeutic strategy for CAD.
  • Further research into inflammatory markers can refine CAD management and prognosis.

More Related Videos

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.4K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

3.6K

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Inflammation01:38

Inflammation

Overview
46.6K